Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge.

Vaccine - 5 Mar 1999

Dean H J, Leyh R

Abstract excerpt

A new genotype of bovine viral diarrhea virus (BVDV), designated BVDV type 2 (BVDV 2), has become prevalent in the field. BVDV 2 strains are antigenically distinct from currently available vaccine strains of the BVDV 1 genotype, raising concerns about cross-protection of these vaccines against BVDV 2 challenge. To determine cross-protective efficacy of a modified-live virus (MLV) vaccine containing BVDV 1 strain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Viral
Share to Bovine Virus Diarrhea-Mucosal Disease
Share to Cattle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line

Share to Immunity, Innate

Share to Viral Vaccines

Share to Virus Shedding

Source

Identifiers

PMID: 10195622
DOI: 10.1016/s0264-410x(98)00329-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge.PMID 10195622Read ↗

Assessment of the clinical and virological protection provided by a commercial inactivated bovine viral diarrhoea virus genotype 1 vaccine against a BVDV genotype 2 challenge.Semantic proximity Read ↗

Impact of species and subgenotypes of bovine viral diarrhea virus on control by vaccination.Semantic proximity Read ↗

Cross-Neutralization between Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2 after Vaccination with a BVDV-1a Modified-Live-VaccineSemantic proximity Read ↗

Prevalence and antigenic differences observed between Bovine viral diarrhea virus subgenotypes isolated from cattle in Australia and feedlots in the southwestern United States.Semantic proximity Read ↗

Host Immune Response to Bovine Viral Diarrhea Virus (BVDV): Insights and Strategies for Effective Vaccine DesignSemantic proximity Read ↗

Serological relationships among subgroups in bovine viral diarrhea virus genotype 1 (BVDV-1).Semantic proximity Read ↗

Transcriptomic analysis among sub-clinically ill cattle following Bovine Respiratory Disease vaccine protocol and challenge with Bovine Viral Diarrhea VirusSemantic proximity Read ↗

Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization.Semantic proximity Read ↗

Novel BVDV-2 mutants as new candidates for modified-live vaccines.Semantic proximity Read ↗

Evolution of bovine viral diarrhea virus vaccines.Semantic proximity Read ↗

Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs.Semantic proximity Read ↗

Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.